SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-141847
Filing Date
2024-05-17
Accepted
2024-05-17 17:01:13
Documents
14
Period of Report
2024-05-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d817743d8k.htm   iXBRL 8-K 26908
  Complete submission text file 0001193125-24-141847.txt   189751

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eftrw-20240516.xsd EX-101.SCH 3911
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftrw-20240516_def.xml EX-101.DEF 14111
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftrw-20240516_lab.xml EX-101.LAB 23322
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftrw-20240516_pre.xml EX-101.PRE 15145
17 EXTRACTED XBRL INSTANCE DOCUMENT d817743d8k_htm.xml XML 5752
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 24961095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)